{"meta":{"query_hash":"5251c2c95b64","filters":{"venue":"European Journal of Drug Metabolism and Pharmacokinetics"},"cohort_total":37,"direct_labels_cover":0,"predictions_cover":37,"exported":37,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/5251c2c95b64","api":"https://metacan.xera.ac/api/v1/cohort?venue=European+Journal+of+Drug+Metabolism+and+Pharmacokinetics"},"results":[{"id":"W1926309879","doi":"10.1007/bf03226382","title":"Assessment of the involvement of CYP3A in the vitro metabolism of a new modulator of MDR in cancer chemotherapy, OC144-193, by human liver microsomes","year":2001,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"CYP3A4; Microsome; CYP3A; Pharmacology; P-glycoprotein; CYP2B6; Ketoconazole; Doxorubicin; Cytochrome P450; In vivo; Drug metabolism; Metabolite; Biology; Chemistry; In vitro; Biochemistry; Multiple drug resistance; Enzyme; Drug; Chemotherapy","score_opus":0.019632549348454664,"score_gpt":0.296693781293974,"score_spread":0.27706123194551935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1926309879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97500914,0.023330586,0.00012316278,0.0005875127,0.0002501368,0.0003248967,0.00005532305,0.0000018148412,0.00031739904],"genre_scores_gemma":[0.97987765,0.018397974,0.00093410484,0.00034968738,0.00018016262,0.0000012680586,0.0000033528218,0.000030321255,0.00022545345],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974864,0.0003451984,0.0012082015,0.00014545381,0.00061151606,0.00020320904],"domain_scores_gemma":[0.998454,0.0000374132,0.0009724528,0.00025070063,0.00018897183,0.000096479635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013243934,0.0002139773,0.0008041615,0.00020434048,0.00002566001,0.0000067229757,0.00041700332,0.000028336905,0.00007624718],"category_scores_gemma":[0.000008074145,0.00012384393,0.0002346715,0.0004107217,0.00017802256,0.00006753632,0.000041468793,0.0003595883,8.0010345e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037367616,0.0007912991,0.013490568,0.00030620937,0.00024326463,0.00003451926,0.005582426,0.00014033947,0.97320986,0.00020367917,0.0007703121,0.004853847],"study_design_scores_gemma":[0.00936165,0.00010451075,0.4703789,0.00049091084,0.00073482515,0.000017764329,0.0007385908,0.000062353145,0.49819332,0.00009033886,0.019684397,0.00014243959],"about_ca_topic_score_codex":0.00013552951,"about_ca_topic_score_gemma":0.000017502158,"teacher_disagreement_score":0.47501653,"about_ca_system_score_codex":0.000014422554,"about_ca_system_score_gemma":0.00012860597,"threshold_uncertainty_score":0.5050209},"labels":[],"label_agreement":null},{"id":"W1969417922","doi":"10.1007/s13318-014-0205-x","title":"A metoprolol–terbinafine combination induced bradycardia","year":2014,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Metoprolol; Bradycardia; Medicine; Sinus bradycardia; Anesthesia; Terbinafine; Bisoprolol; Heart rate; Coronary artery disease; Adverse effect; Cardiology; Internal medicine; Pharmacology; Heart failure; Blood pressure; Dermatology","score_opus":0.0174463820794326,"score_gpt":0.2840406483624154,"score_spread":0.2665942662829828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969417922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98211575,0.004426457,0.0002980386,0.0026202449,0.0012996022,0.0001635608,0.00000460143,0.000020375328,0.009051387],"genre_scores_gemma":[0.9936998,0.0015869954,0.0008067798,0.0019548289,0.0014232431,0.0000011037152,0.0000063639145,0.000035053552,0.00048583667],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983959,0.0005476725,0.0004672516,0.00014519508,0.0002535308,0.000190434],"domain_scores_gemma":[0.9989953,0.00008144972,0.00031490964,0.00011801246,0.00021949648,0.00027081277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010984855,0.00018423307,0.00045734184,0.00020605474,0.000057889272,0.000027125618,0.00011075776,0.00002071951,0.00012290709],"category_scores_gemma":[0.000051382125,0.00014389542,0.00014175012,0.00016301844,0.00005751356,0.00010110339,0.000046897494,0.0003452674,0.000016465443],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025985173,0.00159429,0.0076632835,0.00027625705,0.0015652215,0.0007665164,0.0037591213,0.00004330649,0.4498253,0.0014397549,0.05421735,0.4762511],"study_design_scores_gemma":[0.025237923,0.001358736,0.17090034,0.00008426663,0.00280662,0.0010304692,0.000056622997,0.00042382666,0.054131795,0.00024795008,0.7434121,0.00030934627],"about_ca_topic_score_codex":0.000002764694,"about_ca_topic_score_gemma":2.0991266e-7,"teacher_disagreement_score":0.68919474,"about_ca_system_score_codex":0.000013856444,"about_ca_system_score_gemma":0.0000348468,"threshold_uncertainty_score":0.5867885},"labels":[],"label_agreement":null},{"id":"W1987395036","doi":"10.1007/bf03190076","title":"Metabolism of clozapine by rat brain: the role of flavin-containing monooxygenase (FMO) and cytochrome P450 enzymes","year":2000,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Clozapine; Flavin-containing monooxygenase; Chemistry; Pharmacology; Monooxygenase; Cytochrome P450; Biochemistry; Metabolism; Biology; Medicine; Schizophrenia (object-oriented programming)","score_opus":0.00962137449934509,"score_gpt":0.26108358265706333,"score_spread":0.25146220815771825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987395036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8254722,0.17152931,0.00001391472,0.0019050792,0.00007101655,0.00021747602,0.000058685775,0.0000068703707,0.00072547613],"genre_scores_gemma":[0.9658648,0.031838216,0.000973622,0.00038467793,0.00047689409,0.0000016907303,0.000008535889,0.00004175198,0.0004098428],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976302,0.0006054407,0.00077776547,0.00018969378,0.00050708174,0.00028984633],"domain_scores_gemma":[0.99853283,0.0002072669,0.00038703252,0.00023713597,0.0002354973,0.00040025508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001202418,0.00025880616,0.00069768145,0.00016577664,0.00008753824,0.000032626802,0.00022677366,0.000023318637,0.00029528764],"category_scores_gemma":[0.000090846464,0.00015971797,0.00017446613,0.00021237163,0.0002681767,0.00012647458,0.000075950746,0.0003991904,0.000004281711],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012403749,0.00054329075,0.0005788552,0.00013906205,0.0013350274,0.0004179752,0.0040200804,0.000039082013,0.48486435,0.00060329604,0.0094506545,0.48560455],"study_design_scores_gemma":[0.028120564,0.0009539995,0.07359664,0.00023145947,0.0021874306,0.0010548324,0.0008669031,0.00031131535,0.47292638,0.00035234474,0.41905016,0.00034797346],"about_ca_topic_score_codex":0.000016860295,"about_ca_topic_score_gemma":8.8778114e-7,"teacher_disagreement_score":0.48525658,"about_ca_system_score_codex":0.0000073711594,"about_ca_system_score_gemma":0.000088965775,"threshold_uncertainty_score":0.651311},"labels":[],"label_agreement":null},{"id":"W1996171153","doi":"10.1007/bf03190426","title":"Drug interaction studies between paclitaxel (Taxol) and OC144-093 — A new modulator of MDR in cancer chemotherapy","year":2002,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Paclitaxel; Chemotherapy; Drug; Pharmacology; Cancer; Medicine; Anticancer drug; Cancer chemotherapy; Internal medicine","score_opus":0.04791170190154007,"score_gpt":0.31955224672439864,"score_spread":0.27164054482285854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996171153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.930744,0.066005215,0.000105211206,0.0021292209,0.00050359406,0.00014689461,0.000014544682,0.000008014128,0.0003432968],"genre_scores_gemma":[0.9367045,0.059850506,0.0012079718,0.00029721603,0.0008644738,6.2476863e-7,0.0000012195287,0.00003630694,0.0010371844],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99848986,0.00015665707,0.00071724155,0.00016577472,0.00028106663,0.00018941288],"domain_scores_gemma":[0.99904644,0.000055222008,0.0004034515,0.000107036314,0.00015349835,0.00023435958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060078443,0.00020870869,0.0006653887,0.00023043608,0.000034715944,0.0000147970295,0.00009787,0.000019759384,0.00009742012],"category_scores_gemma":[0.000021039574,0.00015620659,0.00010405423,0.00016025138,0.00009254772,0.00014110278,0.000023166795,0.00035885765,0.0000014776774],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021769141,0.0010218205,0.08969238,0.0017981601,0.0029135668,0.0008205904,0.07209761,0.00032195775,0.121550724,0.00014771707,0.025999548,0.681459],"study_design_scores_gemma":[0.040221557,0.000541478,0.49143162,0.0031267116,0.003835845,0.00026664295,0.005134086,0.0007293085,0.13012148,0.0005746993,0.32300213,0.0010144664],"about_ca_topic_score_codex":0.000015512855,"about_ca_topic_score_gemma":0.00000547714,"teacher_disagreement_score":0.68044454,"about_ca_system_score_codex":0.000015723983,"about_ca_system_score_gemma":0.0000223442,"threshold_uncertainty_score":0.636992},"labels":[],"label_agreement":null},{"id":"W2015768303","doi":"10.1007/bf03190051","title":"Dissolution and in vivo evidence of differences in reference products: impact on development of generic drugs","year":2000,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Apotex (Canada); University of Toronto","funders":"World Health Organization","keywords":"In vivo; Human physiology; Pharmacy; Drug development; Pharmacology; Pharmaceutical technology; Chemistry; Medicine; Drug; Internal medicine; Biology; Biotechnology; Family medicine; Chromatography","score_opus":0.07679717120738065,"score_gpt":0.3537791295833442,"score_spread":0.2769819583759635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015768303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9703095,0.028138136,0.000004972776,0.00048455648,0.00006778807,0.00011094922,0.00000478734,0.000001846749,0.0008774572],"genre_scores_gemma":[0.94304276,0.055817034,0.00091121695,0.00007827526,0.00009163197,4.957419e-7,3.2945417e-7,0.000008273463,0.000049994294],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983799,0.00037028413,0.0006794458,0.00013634983,0.00027594608,0.00015806526],"domain_scores_gemma":[0.99917656,0.00020893365,0.0003195611,0.00007265879,0.000102842176,0.00011943744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012338206,0.00014247057,0.00043937963,0.00014107881,0.000025998743,0.000009258765,0.00009789301,0.000012745634,0.00010847023],"category_scores_gemma":[0.00013320753,0.000092755305,0.00003110404,0.0002541596,0.00009852325,0.00013836694,0.000039667302,0.00029145335,8.7259485e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0123113,0.0013976304,0.08208714,0.0014832547,0.00039735032,0.00019278684,0.020600311,0.0002153225,0.24742475,0.000026818618,0.000529579,0.63333374],"study_design_scores_gemma":[0.003530834,0.0003895049,0.9217333,0.0013480231,0.00026496977,0.000052855015,0.00032401737,0.00019773153,0.05756448,0.000013496291,0.014405946,0.00017481671],"about_ca_topic_score_codex":0.000008005978,"about_ca_topic_score_gemma":0.0000014259978,"teacher_disagreement_score":0.8396462,"about_ca_system_score_codex":0.0000137821,"about_ca_system_score_gemma":0.00006370093,"threshold_uncertainty_score":0.37824517},"labels":[],"label_agreement":null},{"id":"W2021808739","doi":"10.1007/bf03190602","title":"Metabolic and pharmacokinetic evaluation of a Novel 3-hydroxypyridinone iron chelator, CP502, in the rat","year":2004,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Apotex (Canada); University of Toronto","funders":"","keywords":"Pharmacokinetics; Bioavailability; Pharmacology; Chemistry; Urine; Oral administration; Dosing; Clinical chemistry; Potency; Chelation; Excretion; Medicine; Biochemistry; In vitro","score_opus":0.022969647272310715,"score_gpt":0.28807151443531054,"score_spread":0.2651018671629998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021808739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9234132,0.0721593,0.00011536892,0.0019010641,0.00040470663,0.00037268313,0.000007397448,0.0000058836713,0.0016204066],"genre_scores_gemma":[0.9758264,0.022435319,0.00067205075,0.0006857806,0.00032141985,0.0000017311177,0.000003044828,0.000032781772,0.000021485832],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974583,0.00056072633,0.000801871,0.00018099572,0.0007596681,0.00023843614],"domain_scores_gemma":[0.9988603,0.00006351458,0.0004304899,0.00016560976,0.00029692615,0.0001831547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003919547,0.00023302996,0.0004978167,0.00027627492,0.000059468854,0.000028051416,0.0001810376,0.000035140107,0.00003316117],"category_scores_gemma":[0.00012481418,0.00014931345,0.00011832931,0.000401335,0.00019191355,0.00012881498,0.00005424747,0.0005850722,0.0000019646477],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015537359,0.0036160622,0.0026295104,0.00067774474,0.0008710035,0.00055464974,0.0361299,0.019260533,0.72573346,0.00181336,0.001570823,0.20558922],"study_design_scores_gemma":[0.25329664,0.0014104136,0.35295233,0.0018372873,0.027232166,0.0086564375,0.008755065,0.01500947,0.17075641,0.00094920554,0.15741582,0.0017287593],"about_ca_topic_score_codex":0.000010453576,"about_ca_topic_score_gemma":6.288736e-7,"teacher_disagreement_score":0.55497706,"about_ca_system_score_codex":0.000013581693,"about_ca_system_score_gemma":0.000113877024,"threshold_uncertainty_score":0.60888255},"labels":[],"label_agreement":null},{"id":"W2061416714","doi":"10.1007/bf03190370","title":"Induction and inactivation of a cytochrome P450 confering herbicide resistance in wheat seedlings","year":2001,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Weed Control and Herbicide Applications","field":"Agricultural and Biological Sciences","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bentazon; Cytochrome P450; Lauric acid; Hydroxylation; Chemistry; Enzyme; In vivo; Metabolism; Biochemistry; Monooxygenase; Biology; Fatty acid; Botany","score_opus":0.01697965664784809,"score_gpt":0.23388240194586643,"score_spread":0.21690274529801834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061416714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938541,0.0033106618,0.000048371898,0.0015411336,0.000042050193,0.000078139645,0.000004038359,0.000005298545,0.0011162069],"genre_scores_gemma":[0.9976554,0.0015018167,0.00033685038,0.00011234304,0.00031151614,8.5734246e-7,0.000001678278,0.0000017281975,0.00007784549],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991482,0.00014808266,0.00037420017,0.000101452715,0.00012092515,0.000107145286],"domain_scores_gemma":[0.9994674,0.00006764298,0.00025645448,0.000026415546,0.0001095641,0.000072570234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052335527,0.00008789482,0.00019447293,0.000039486786,0.000052826672,0.000027481452,0.00009611306,0.000012720347,0.000024363973],"category_scores_gemma":[0.000023032035,0.00004302656,0.000031028198,0.00021444545,0.000049320384,0.00015741165,0.00002833486,0.00016168733,6.170463e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009465523,0.00003155551,0.00081372214,0.000009218277,0.000010448344,0.000008493565,0.00041235922,0.00001388263,0.96865183,0.00024410096,0.00005152035,0.029658224],"study_design_scores_gemma":[0.00080857135,0.000040722054,0.95140016,0.00006630511,0.00004671136,0.00003968899,0.0003094887,0.000036316822,0.011024945,0.0005253304,0.035602827,0.000098954784],"about_ca_topic_score_codex":0.00005695117,"about_ca_topic_score_gemma":0.00004623895,"teacher_disagreement_score":0.9576269,"about_ca_system_score_codex":0.0000057869124,"about_ca_system_score_gemma":0.0000051071756,"threshold_uncertainty_score":0.17545722},"labels":[],"label_agreement":null},{"id":"W2072862596","doi":"10.1007/s13318-011-0072-7","title":"Metabolism studies of a small-molecule tumor necrosis factor-alpha (TNF-α) inhibitor, UTL-5b (GBL-5b)","year":2011,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health","keywords":"Leflunomide; Chemistry; Microsome; In vitro; Tumor necrosis factor alpha; Metabolism; Pharmacology; Metabolite; Biochemistry; Medicine; Internal medicine","score_opus":0.04177131014717696,"score_gpt":0.28112694570512564,"score_spread":0.2393556355579487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072862596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9585925,0.03652922,0.00013692385,0.0001188086,0.0024259402,0.00031772227,0.00003564796,0.000031505842,0.0018117285],"genre_scores_gemma":[0.9865171,0.0072763525,0.0032958982,0.00068769505,0.0018453692,0.0000029100488,0.0000028901104,0.00011137307,0.00026043385],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99657947,0.0006601625,0.0013678405,0.00030933047,0.000607131,0.00047605226],"domain_scores_gemma":[0.9971224,0.00013872444,0.0010285652,0.00032409525,0.0007758483,0.00061034015],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016855632,0.0004896732,0.0013237325,0.0004155585,0.00011353559,0.000030000603,0.00032474997,0.00004292691,0.0001494948],"category_scores_gemma":[0.00032726166,0.00036570855,0.0003962493,0.0003284427,0.0003242952,0.00019125757,0.00018925764,0.00067339436,0.000020382322],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046561374,0.0019383966,0.00810648,0.0030076306,0.005131108,0.0064637107,0.07177692,0.0000140031425,0.8199922,0.000980805,0.018343003,0.05958963],"study_design_scores_gemma":[0.0125866225,0.000684773,0.06727109,0.00069405703,0.003886598,0.00071626995,0.0008413655,0.000051701503,0.8350141,0.00010751171,0.07744678,0.00069913134],"about_ca_topic_score_codex":0.000009166207,"about_ca_topic_score_gemma":8.3604874e-7,"teacher_disagreement_score":0.070935555,"about_ca_system_score_codex":0.00002303224,"about_ca_system_score_gemma":0.00017153978,"threshold_uncertainty_score":0.9998795},"labels":[],"label_agreement":null},{"id":"W2081266165","doi":"10.1007/bf03190054","title":"Differences in reference products: dissolution and in vivo evidence","year":2000,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Pharmacists Association","funders":"","keywords":"Human physiology; In vivo; Dissolution; Clinical chemistry; Chemistry; Medicine; Pharmacology; Internal medicine; Biology; Biotechnology","score_opus":0.33785891534596624,"score_gpt":0.46446672292087726,"score_spread":0.12660780757491102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081266165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918068,0.0052938755,0.00049230247,0.0006742135,0.0003021578,0.00016698614,0.000015566455,0.000008195078,0.001239877],"genre_scores_gemma":[0.8895016,0.020501954,0.089314125,0.000100318946,0.00037061985,0.0000010726694,7.83181e-8,0.0000189813,0.00019125783],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99532473,0.0027621605,0.0011668298,0.00023193065,0.0002940727,0.00022028598],"domain_scores_gemma":[0.9941751,0.0051018503,0.00033564502,0.0001423499,0.00009974176,0.00014531128],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.005819577,0.00017180236,0.00056528556,0.00013436087,0.000030237223,0.00004988605,0.00020405272,0.000025989038,0.00025217043],"category_scores_gemma":[0.009981369,0.00012929349,0.000031442483,0.00025997,0.00017183615,0.00018106149,0.000062262705,0.00052657886,0.0000030706346],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005129116,0.0018547341,0.030916313,0.0017303333,0.00023723161,0.0017981416,0.010810055,0.00006048572,0.04429106,0.013923169,0.0077525973,0.8814968],"study_design_scores_gemma":[0.013663983,0.0005677474,0.68295634,0.004505835,0.0009367358,0.0004030037,0.0004722383,0.0010906939,0.013928711,0.2501215,0.029960005,0.0013931922],"about_ca_topic_score_codex":0.000003882552,"about_ca_topic_score_gemma":0.0000017549144,"teacher_disagreement_score":0.8801036,"about_ca_system_score_codex":0.000008952377,"about_ca_system_score_gemma":0.000023494511,"threshold_uncertainty_score":0.99835795},"labels":[],"label_agreement":null},{"id":"W2084480461","doi":"10.1007/bf03190061","title":"Realities and implementation — report of the International Workshop on IBE, Montreal, Canada, August 1999","year":2000,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Mathematics Education and Programs","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Human physiology; Library science; Political science; Medicine; Internal medicine; Computer science","score_opus":0.028822042495909753,"score_gpt":0.3203651844755462,"score_spread":0.29154314197963643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084480461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9715897,0.00095349853,0.00005431989,0.002449023,0.0008018999,0.00015073908,0.000041215957,0.000006415136,0.023953198],"genre_scores_gemma":[0.98821235,0.0026405724,0.002217697,0.00050281145,0.0005168059,0.0000013472222,0.0000066433645,0.000028902135,0.0058728503],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985349,0.00022394187,0.0006587539,0.00009030522,0.00038714035,0.00010493692],"domain_scores_gemma":[0.998876,0.00018047771,0.00055497914,0.00015135018,0.0001418516,0.00009537845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009629143,0.00011831643,0.0001960669,0.000050525425,0.00006292186,0.000047664358,0.00021702827,0.000009379181,0.00057663786],"category_scores_gemma":[0.000090657086,0.00008048509,0.00005289355,0.000079117046,0.000055104545,0.00005861948,0.000036433295,0.00016651108,5.0643587e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017785093,0.00033089926,0.0012017424,0.00023349497,0.0004551309,0.00014948192,0.014097229,0.000064132866,0.00051543646,0.0084534045,0.55101013,0.42331105],"study_design_scores_gemma":[0.0024740826,0.00004033739,0.027277555,0.00022876644,0.0004975707,0.00074923766,0.0035263188,0.00010642512,0.0043313885,0.008518515,0.9519711,0.0002786744],"about_ca_topic_score_codex":0.0018294817,"about_ca_topic_score_gemma":0.0016674575,"teacher_disagreement_score":0.42303237,"about_ca_system_score_codex":0.000011624797,"about_ca_system_score_gemma":0.0000911953,"threshold_uncertainty_score":0.63137805},"labels":[],"label_agreement":null},{"id":"W2084505805","doi":"10.1007/s13318-014-0243-4","title":"Placental profiling of UGT1A enzyme expression and activity and interactions with preeclampsia at term","year":2014,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"National Institute on Minority Health and Health Disparities; National Center for Research Resources; National Institute of General Medical Sciences; National Institutes of Health","keywords":"Placenta; Biology; Fetus; Microsome; Enzyme; Glucuronosyltransferase; Preeclampsia; Messenger RNA; Andrology; Endocrinology; Pregnancy; Biochemistry; Internal medicine; Gene; Medicine; Genetics","score_opus":0.015217876883874286,"score_gpt":0.26610746491165327,"score_spread":0.250889588027779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084505805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872813,0.008851791,0.0005106875,0.00023452708,0.00016931836,0.00014053303,0.000011049479,0.000008533108,0.0027922345],"genre_scores_gemma":[0.9925934,0.0034694595,0.0033538935,0.00006695369,0.00026083918,8.1505885e-7,0.0000015501137,0.000020911064,0.00023216529],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99894464,0.00030810543,0.00028702043,0.00014530377,0.000183663,0.00013124598],"domain_scores_gemma":[0.9991977,0.00012213904,0.00032710622,0.00010051435,0.000083685736,0.00016882106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045563705,0.00016213206,0.00036757052,0.000089810914,0.00010554435,0.000016716733,0.000056675002,0.000013596075,0.000012216278],"category_scores_gemma":[0.00003799999,0.000109614375,0.000041595024,0.000053896525,0.00017320392,0.00015795742,0.00013632995,0.0002895578,4.0509036e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035316143,0.00025128762,0.061474368,0.00078866223,0.00039414628,0.00009730481,0.006991006,0.00001771081,0.8926021,0.000065937,0.000936487,0.032849383],"study_design_scores_gemma":[0.010123327,0.00039989917,0.3512682,0.0015625508,0.0012128376,0.0012386324,0.0003330866,0.00026759232,0.6113971,0.000031674273,0.021879291,0.00028585125],"about_ca_topic_score_codex":7.571941e-7,"about_ca_topic_score_gemma":0.0000011220704,"teacher_disagreement_score":0.28979382,"about_ca_system_score_codex":0.0000054720904,"about_ca_system_score_gemma":0.000012591003,"threshold_uncertainty_score":0.44699445},"labels":[],"label_agreement":null},{"id":"W2129688365","doi":"10.1007/s13318-010-0005-x","title":"Survey: calculation of the characteristics of oral diffusion-controlled release dosage forms related to the drug","year":2010,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Drug Solubulity and Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University","funders":"","keywords":"Dosage form; Drug; Pharmacokinetics; Pharmacology; Diffusion; In vivo; Chemistry; Bioavailability; Biomedical engineering; Chromatography; Medicine; Thermodynamics; Physics; Biotechnology","score_opus":0.029386055024585037,"score_gpt":0.32721896644109405,"score_spread":0.297832911416509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129688365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903108,0.0012560313,0.00007259934,0.0013958378,0.0051334575,0.00057786657,0.00021254316,0.000010799468,0.0010300905],"genre_scores_gemma":[0.99719024,0.00073007157,0.00008103517,0.0007254704,0.00035439324,0.0000023062225,0.0000103463635,0.000035816847,0.00087034155],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9936561,0.0037810884,0.0016284317,0.00018846871,0.00044666434,0.00029922498],"domain_scores_gemma":[0.9964623,0.00073225505,0.0015517672,0.00034443324,0.0006040651,0.00030517473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008166224,0.00027855427,0.00077388674,0.00014791619,0.00024955207,0.000033672353,0.0007632866,0.00008286924,0.00018471919],"category_scores_gemma":[0.0006394169,0.00015542617,0.00031369808,0.0004128535,0.00032717755,0.00013422915,0.00023004158,0.0014127854,0.000014435804],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01563929,0.002790273,0.17349298,0.00057091506,0.0032291233,0.00021628628,0.043085225,0.0048608123,0.52115077,0.0026071756,0.049601458,0.1827557],"study_design_scores_gemma":[0.015414685,0.00011914556,0.6794595,0.000090772824,0.0017063437,0.000127109,0.0003073346,0.0056183646,0.021336818,0.0001006446,0.27529988,0.00041937057],"about_ca_topic_score_codex":0.00003409423,"about_ca_topic_score_gemma":0.00002553006,"teacher_disagreement_score":0.50596654,"about_ca_system_score_codex":0.000008209851,"about_ca_system_score_gemma":0.00008346918,"threshold_uncertainty_score":0.6338095},"labels":[],"label_agreement":null},{"id":"W2299666588","doi":"10.1007/s13318-016-0322-9","title":"Pharmacokinetic Time Course Scaling of a Subcutaneously Administered Pegylated Peptide Conjugate for a First-in-Human Investigation","year":2016,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Advancements in Transdermal Drug Delivery","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Pharmacokinetics; Human physiology; Conjugate; Peptide; Clinical chemistry; Pharmacology; Medicine; PEGylation; Medical physics; Chemistry; Internal medicine; Biochemistry; Mathematics; Polyethylene glycol","score_opus":0.05078384283950307,"score_gpt":0.36189093232493424,"score_spread":0.3111070894854312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2299666588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99116707,0.0037799738,0.0012675702,0.001372293,0.0010273517,0.0006168941,0.00025081125,0.000030888106,0.00048713942],"genre_scores_gemma":[0.9935241,0.0031498938,0.0013420349,0.0006858806,0.0005342104,0.000007697024,0.000012079441,0.00008734611,0.0006567905],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959657,0.0012410679,0.0016036137,0.00033993967,0.0003244688,0.0005252105],"domain_scores_gemma":[0.9970906,0.00077922305,0.001075395,0.00017951969,0.0004428339,0.00043244424],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022973025,0.00040282807,0.0007067563,0.00031484145,0.00015976629,0.000023031447,0.00049915904,0.00007952832,0.00043578362],"category_scores_gemma":[0.00012628295,0.00032348227,0.00020516163,0.00024193391,0.000513309,0.0002729555,0.000090737594,0.00060260855,0.000018311086],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026752886,0.0005160019,0.0019013811,0.00035386972,0.0005907838,0.00051577605,0.002944704,0.002481022,0.95104265,0.00022448703,0.0031021931,0.03365183],"study_design_scores_gemma":[0.058826033,0.0012088786,0.009382121,0.0012029809,0.0046139564,0.0008919142,0.00032268764,0.009630946,0.6484055,0.0013205049,0.2625653,0.0016291474],"about_ca_topic_score_codex":0.0000021130088,"about_ca_topic_score_gemma":0.0000017419989,"teacher_disagreement_score":0.30263716,"about_ca_system_score_codex":0.000033854958,"about_ca_system_score_gemma":0.00008907315,"threshold_uncertainty_score":0.99992174},"labels":[],"label_agreement":null},{"id":"W2403613290","doi":"10.1007/s13318-016-0348-z","title":"Proposing the Use of Partial AUC as an Adjunctive Measure in Establishing Bioequivalence Between Deltoid and Gluteal Administration of Long-Acting Injectable Antipsychotics","year":2016,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Provincial Health Services Authority; University of British Columbia","funders":"Canadian Institutes of Health Research; BC Mental Health and Substance Use Services","keywords":"Bioequivalence; Pharmacokinetics; Medicine; Pharmacology; Plasma concentration; Area under the curve","score_opus":0.10475735469394125,"score_gpt":0.3581629305154335,"score_spread":0.25340557582149226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403613290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931478,0.003726109,0.0011160412,0.0014060506,0.00023552313,0.0001795191,0.000021823074,0.000004568089,0.00016257288],"genre_scores_gemma":[0.99118483,0.0066845417,0.0015092753,0.00012315362,0.00046374288,3.086559e-7,0.0000011062818,0.00001940943,0.000013642169],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977262,0.00082109834,0.0007094072,0.0001604073,0.00037644093,0.00020646432],"domain_scores_gemma":[0.9980799,0.00059623993,0.0007111829,0.00011480859,0.0003113807,0.00018646993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021381786,0.00015828275,0.00040966689,0.00009789255,0.0000877373,0.000057433215,0.00012857503,0.000023203827,0.000012441592],"category_scores_gemma":[0.0006556902,0.00008963483,0.000054480166,0.0002049506,0.00024297452,0.0007456907,0.000074092524,0.00036575546,2.6072792e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009024038,0.00055627007,0.14773506,0.00043600262,0.00064961135,0.00034911057,0.008278677,0.00007122807,0.21107005,0.00012537124,0.00024448533,0.62146014],"study_design_scores_gemma":[0.0144726075,0.0022955155,0.5863931,0.0020556196,0.004119556,0.0008183877,0.0019167815,0.00068041927,0.34609842,0.00014396508,0.040426217,0.00057936524],"about_ca_topic_score_codex":0.000016926828,"about_ca_topic_score_gemma":0.0000026212708,"teacher_disagreement_score":0.6208807,"about_ca_system_score_codex":0.0000087619355,"about_ca_system_score_gemma":0.00007519522,"threshold_uncertainty_score":0.3655202},"labels":[],"label_agreement":null},{"id":"W2582578406","doi":"10.1007/s13318-016-0398-2","title":"Systemic Bioavailability and Dose Proportionality of Omega-3 Administered in Free Fatty Acid Form Compared With Ethyl Ester Form: Results of a Phase 1 Study in Healthy Volunteers","year":2017,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"AstraZeneca","keywords":"Bioavailability; Eicosapentaenoic acid; Pharmacokinetics; Clinical chemistry; Docosahexaenoic acid; Dosing; Chemistry; Fatty acid; Ethyl ester; Medicine; Omega 3 fatty acid; Pharmacology; Animal science; Biochemistry; Polyunsaturated fatty acid; Biology; Organic chemistry","score_opus":0.05782530799352601,"score_gpt":0.3675605375013026,"score_spread":0.30973522950777654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582578406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99320364,0.003378761,0.000043307933,0.0018011444,0.00033295693,0.00087176845,0.00023851657,0.0000048292845,0.00012508497],"genre_scores_gemma":[0.9980166,0.0006757003,0.0010777104,0.00007175221,0.00011689363,0.0000027782612,0.0000055355176,0.000024572957,0.000008481446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99574316,0.001246296,0.0017363469,0.00028648812,0.00060535275,0.00038234156],"domain_scores_gemma":[0.9971657,0.000116887066,0.0014426261,0.00052125106,0.00040298572,0.00035058474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061433376,0.00022678671,0.0008201438,0.00032975813,0.00012758415,0.00006358786,0.0005024376,0.000030591265,0.000005580027],"category_scores_gemma":[0.00041839306,0.00017057727,0.000064863285,0.00017954147,0.00046206385,0.0004092216,0.0001722211,0.00062848936,4.5185146e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24571835,0.013103741,0.51140994,0.0076493328,0.00045615944,0.0009686538,0.08895974,0.00009180845,0.056089994,0.000037390186,0.0015462334,0.073968664],"study_design_scores_gemma":[0.08587924,0.0043800585,0.89083266,0.0008981328,0.0001830628,0.00016739908,0.0033825564,0.0004937838,0.012680865,0.0000748229,0.0007485965,0.00027882267],"about_ca_topic_score_codex":0.00030177605,"about_ca_topic_score_gemma":0.00029309213,"teacher_disagreement_score":0.37942272,"about_ca_system_score_codex":0.000043987107,"about_ca_system_score_gemma":0.0001589618,"threshold_uncertainty_score":0.69559395},"labels":[],"label_agreement":null},{"id":"W2766243414","doi":"10.1007/s13318-017-0440-z","title":"Safety, Tolerability and Pharmacokinetics of Oral BI 425809, a Glycine Transporter 1 Inhibitor, in Healthy Male Volunteers: A Partially Randomised, Single-Blind, Placebo-Controlled, First-in-Human Study","year":2017,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Amino Acid Enzymes and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Pharmacokinetics; Tolerability; Pharmacology; NMDA receptor; Placebo; Adverse effect; Medicine; Bioavailability; Oral administration; Internal medicine; Endocrinology; Receptor","score_opus":0.018815103319660586,"score_gpt":0.2862118875924309,"score_spread":0.2673967842727703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766243414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98767537,0.00939802,0.00020267635,0.0004748641,0.00069969,0.0010593568,0.000047642283,0.000004405949,0.00043796524],"genre_scores_gemma":[0.9924273,0.005968914,0.0004628612,0.00018167711,0.00074028206,0.000009795205,0.000010705105,0.000057020065,0.00014143421],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99608845,0.00084032386,0.0018069777,0.00046288167,0.0003544856,0.0004468974],"domain_scores_gemma":[0.99796003,0.00005324356,0.0009779275,0.00045242708,0.00023237044,0.00032398294],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032100694,0.0004310372,0.0012553242,0.00023441795,0.00017273834,0.00008595143,0.0005085986,0.000069018744,0.000044031163],"category_scores_gemma":[0.00015184714,0.00036463208,0.00022536003,0.000104720515,0.00030123026,0.000049158847,0.00019891195,0.00045897334,6.8417467e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3542896,0.0064318064,0.1071884,0.0005528483,0.0012218627,0.0009270715,0.008352061,0.0021403066,0.48129666,0.000039340674,0.001560468,0.035999585],"study_design_scores_gemma":[0.7184865,0.0030501862,0.1568253,0.00023862351,0.0016794192,0.00019831971,0.0009186256,0.0005755968,0.037318252,0.000026781743,0.07962303,0.0010593814],"about_ca_topic_score_codex":0.00006719729,"about_ca_topic_score_gemma":0.00022687913,"teacher_disagreement_score":0.4439784,"about_ca_system_score_codex":0.000012082338,"about_ca_system_score_gemma":0.0000749556,"threshold_uncertainty_score":0.99988055},"labels":[],"label_agreement":null},{"id":"W2790570760","doi":"10.1007/s13318-018-0471-0","title":"Clinical Pharmacokinetics and Drug–Drug Interactions of Elbasvir/Grazoprevir","year":2018,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Hepatitis C virus research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Pharmacokinetics; Pharmacology; Drug interaction; Drug; Internal medicine","score_opus":0.04938803418078314,"score_gpt":0.3939503694461836,"score_spread":0.3445623352654005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790570760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745513,0.01073468,0.00032839246,0.0018793959,0.0015476921,0.0002791563,0.000052770625,0.000020011872,0.010606583],"genre_scores_gemma":[0.95138675,0.03846399,0.004528721,0.0008684124,0.0033049735,9.2873785e-7,0.000004222087,0.00007249729,0.001369504],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99563205,0.0014430017,0.0016033209,0.00029882338,0.0006577219,0.000365077],"domain_scores_gemma":[0.9968683,0.00040091018,0.00069913553,0.00029427308,0.0009856195,0.0007517733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035345342,0.00029066115,0.00082390103,0.00040510087,0.000113438735,0.000053907657,0.0003145061,0.000021503005,0.00048300368],"category_scores_gemma":[0.00042272249,0.00023620567,0.00023685822,0.00034903357,0.0007744519,0.00022576145,0.00026122227,0.0010925309,0.000041695894],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019490577,0.001110421,0.055847224,0.0005397772,0.001322682,0.0007993142,0.0049390513,0.0000104841665,0.07178671,0.00014993823,0.13901585,0.7225295],"study_design_scores_gemma":[0.0070360205,0.00028975293,0.062191337,0.0003395069,0.0013424256,0.00038944776,0.0002010346,0.0006297007,0.026816128,0.00004170625,0.9004517,0.00027121062],"about_ca_topic_score_codex":0.000011604808,"about_ca_topic_score_gemma":0.0000036123536,"teacher_disagreement_score":0.76143587,"about_ca_system_score_codex":0.000012876291,"about_ca_system_score_gemma":0.00011873381,"threshold_uncertainty_score":0.96321875},"labels":[],"label_agreement":null},{"id":"W2896125532","doi":"10.1007/s13318-018-0520-8","title":"Clinical Pharmacokinetics and Pharmacodynamics of Delafloxacin","year":2018,"lang":"en","type":"review","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Alberta Health Services","funders":"","keywords":"Medicine; Pharmacology; Pharmacokinetics; Pharmacodynamics; Chronic bronchitis; Drug; Bioavailability; Acute Pharyngitis; In vivo; Internal medicine; Pharyngitis","score_opus":0.05655088689311385,"score_gpt":0.38965559840787034,"score_spread":0.3331047115147565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896125532","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007734111,0.9868035,0.00041013918,0.00011237383,0.002629261,0.0006803572,0.00019399775,0.000027192658,0.0014091001],"genre_scores_gemma":[0.0045496873,0.98407614,0.00577799,0.00034427695,0.0045630625,8.817976e-7,0.000039406863,0.00027221767,0.0003763294],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99209696,0.001658132,0.0042444915,0.00064977945,0.0007675641,0.0005830929],"domain_scores_gemma":[0.99368215,0.0005198516,0.0032828425,0.00047536378,0.00091308425,0.001126688],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0041345335,0.0009972885,0.0042681745,0.00076330686,0.000103795894,0.00007486874,0.0006362253,0.00018064708,0.00012825015],"category_scores_gemma":[0.00022117699,0.0007689451,0.0011708944,0.0005572568,0.0009954467,0.00012145768,0.0005187821,0.0020446768,0.000022719845],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003373519,0.0006068847,0.00008973225,0.01291646,0.0022989672,0.00068395183,0.00027720028,0.00000438804,0.0002155121,0.00006118361,0.013217956,0.96929044],"study_design_scores_gemma":[0.0058854907,0.0004494032,0.00024670674,0.005676185,0.023114802,0.0018596528,0.000029873869,0.00039099655,0.0001744692,0.000013205134,0.9615415,0.0006177372],"about_ca_topic_score_codex":0.0000011735544,"about_ca_topic_score_gemma":8.107861e-8,"teacher_disagreement_score":0.9686727,"about_ca_system_score_codex":0.000024843095,"about_ca_system_score_gemma":0.00035285126,"threshold_uncertainty_score":0.99947613},"labels":[],"label_agreement":null},{"id":"W2899367089","doi":"10.1007/s13318-018-0525-3","title":"Population Pharmacokinetic Analysis of Immediate-Release Oral Tacrolimus Co-administered with Mycophenolate Mofetil in Corticosteroid-Free Adult Kidney Transplant Recipients","year":2018,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of British Columbia; University of Alberta","funders":"Vancouver Coastal Health Research Institute; F. Hoffmann-La Roche","keywords":"Tacrolimus; Mycophenolic acid; Pharmacokinetics; Population; Medicine; Calcineurin; Pharmacology; Mycophenolate; Renal function; Corticosteroid; Therapeutic drug monitoring; Kidney transplantation; Transplantation; Urology; Internal medicine","score_opus":0.01677122219796305,"score_gpt":0.29372074571092094,"score_spread":0.2769495235129579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899367089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974993,0.00055894605,0.00026185458,0.0002580966,0.00041178736,0.00024698273,0.00028153104,0.000010454991,0.0004710812],"genre_scores_gemma":[0.9949341,0.0026808537,0.0012821411,0.0006331702,0.00018804135,0.0000014892544,0.00013689316,0.000044547058,0.00009875856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99733865,0.0004080512,0.0011639434,0.00024920233,0.00055285014,0.0002873297],"domain_scores_gemma":[0.99812007,0.00006442222,0.00069608435,0.00023742173,0.00037398457,0.0005080421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045947154,0.00030013738,0.00087712565,0.00073390175,0.00005108963,0.000028579285,0.00020598926,0.000024821902,0.00012969186],"category_scores_gemma":[0.000039785296,0.0002150249,0.00019745575,0.00071785453,0.0001311286,0.00015088533,0.000020640216,0.00026376778,0.000005002119],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023594152,0.0014849195,0.9103847,0.0005318833,0.0067102415,0.003357461,0.007121808,0.0006750594,0.02621299,0.000026634236,0.00035776998,0.01954236],"study_design_scores_gemma":[0.030656079,0.00076802546,0.9448559,0.0005826213,0.011543641,0.00028514315,0.000063467865,0.0013725347,0.009008186,0.000008440285,0.00061891385,0.00023701452],"about_ca_topic_score_codex":0.00003616465,"about_ca_topic_score_gemma":0.00001014548,"teacher_disagreement_score":0.034471214,"about_ca_system_score_codex":0.00002036387,"about_ca_system_score_gemma":0.000051407387,"threshold_uncertainty_score":0.87684613},"labels":[],"label_agreement":null},{"id":"W2903610462","doi":"10.1007/s13318-018-0533-3","title":"Advanced In Vitro HepaRG Culture Systems for Xenobiotic Metabolism and Toxicity Characterization","year":2018,"lang":"en","type":"review","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Liver physiology and pathology","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Health Sciences Centre","funders":"","keywords":"Toxicity; Drug metabolism; Scaffold; Spheroid; In vitro; 3D cell culture; Xenobiotic; Cell biology; Cellular model; Function (biology); Pregnane X receptor; Biology; Cell culture; Pharmacology; Chemistry; Computational biology; Drug; Biochemistry; Biomedical engineering; Nuclear receptor; Medicine","score_opus":0.02906675438507547,"score_gpt":0.3145566897358853,"score_spread":0.2854899353508098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903610462","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014712936,0.98183334,0.00017976805,0.000044184537,0.002005163,0.0008310552,0.00025888355,0.000011815921,0.00012282656],"genre_scores_gemma":[0.003621686,0.9918628,0.00081662805,0.00023672011,0.0028846513,0.000006800419,0.0001830211,0.00007423011,0.00031350332],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967759,0.0012603502,0.0011606896,0.00034492105,0.00015660329,0.00030150288],"domain_scores_gemma":[0.9980526,0.00012228084,0.0011283829,0.0001865062,0.0002690044,0.00024122883],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012554831,0.00045377438,0.0023606198,0.00031486677,0.00007790802,0.000036369674,0.00020069124,0.0001319681,0.000007884432],"category_scores_gemma":[0.00010005858,0.0003169729,0.00027393972,0.00019901515,0.00017156493,0.00013961771,0.000087406064,0.0006922415,0.000005373919],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021832152,0.0005192623,0.000017293834,0.035635136,0.0016217126,0.00073096534,0.0035882606,0.000005325449,0.083302155,0.00016543917,0.0023533837,0.8698779],"study_design_scores_gemma":[0.0030879143,0.00015574542,0.0004511301,0.0025534616,0.004189842,0.0010865064,0.00002545789,0.000028813187,0.0006782857,0.000010590845,0.98744285,0.00028939988],"about_ca_topic_score_codex":4.6460377e-7,"about_ca_topic_score_gemma":4.109092e-8,"teacher_disagreement_score":0.9850895,"about_ca_system_score_codex":0.000014814379,"about_ca_system_score_gemma":0.000090622176,"threshold_uncertainty_score":0.99992824},"labels":[],"label_agreement":null},{"id":"W2941839579","doi":"10.1007/s13318-019-00553-z","title":"Predictability of Capillary Blood Spot Toward Venous Whole Blood Sampling for Therapeutic Drug Monitoring of Tacrolimus in Solid Organ Transplant Recipients","year":2019,"lang":"en","type":"review","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Alberta","funders":"","keywords":"Tacrolimus; Therapeutic drug monitoring; Medicine; Drug; Dried blood spot; Whole blood; Organ transplantation; Intensive care medicine; Venous blood; Internal medicine; Pharmacology; Transplantation; Chemistry; Chromatography","score_opus":0.07249983486276743,"score_gpt":0.34793842134482544,"score_spread":0.275438586482058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941839579","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.063727096,0.93286806,0.0001343583,0.0000357953,0.0020676334,0.00053070113,0.0006010085,0.0000068585286,0.000028458593],"genre_scores_gemma":[0.09241773,0.9055971,0.0014699113,0.000019402116,0.00032971767,0.0000023305442,0.0000233049,0.00006928039,0.000071201306],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951273,0.0018210721,0.0021216099,0.00036145077,0.00013814634,0.00043037639],"domain_scores_gemma":[0.99721074,0.00063497416,0.0015008502,0.00029413344,0.0002673934,0.00009188094],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030070338,0.0004888772,0.0027401971,0.00033518331,0.00005307567,0.000016596712,0.0006362339,0.00017732548,0.00003018149],"category_scores_gemma":[0.00008863928,0.00035750566,0.0006511749,0.00026694115,0.00023922586,0.00006251962,0.00010959285,0.0010078646,0.0000016810585],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088516524,0.002534359,0.0020465525,0.023605295,0.006175382,0.00009604713,0.004266099,0.000024510513,0.059696645,0.000022437589,0.000099116674,0.9005484],"study_design_scores_gemma":[0.013574214,0.0012955369,0.005115549,0.020181354,0.047191743,0.00092293863,0.0002946723,0.0000049569617,0.0939997,0.00008166933,0.8161134,0.0012242644],"about_ca_topic_score_codex":0.000003605467,"about_ca_topic_score_gemma":2.3575932e-7,"teacher_disagreement_score":0.8993241,"about_ca_system_score_codex":0.000011933637,"about_ca_system_score_gemma":0.0001460167,"threshold_uncertainty_score":0.9998877},"labels":[],"label_agreement":null},{"id":"W2998860412","doi":"10.1007/s13318-019-00601-8","title":"Is Therapeutic Drug Monitoring of Lacosamide Needed in Patients with Seizures and Epilepsy?","year":2020,"lang":"en","type":"review","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Lacosamide; Medicine; Pharmacokinetics; Pharmacology; Therapeutic drug monitoring; Carbamazepine; Phenytoin; Drug; Epilepsy; Intensive care medicine; Psychiatry","score_opus":0.03703921092062795,"score_gpt":0.32222124884068354,"score_spread":0.2851820379200556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998860412","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08282461,0.91594315,0.0000052444793,0.0002534462,0.00031158578,0.0004495557,0.00003964307,0.000007834093,0.00016493806],"genre_scores_gemma":[0.093329445,0.9053609,0.0002882335,0.0003691318,0.0005559163,0.0000016462365,0.0000029932182,0.000056399178,0.000035327135],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99742246,0.00074525183,0.0009552425,0.0002472005,0.00039365297,0.00023618969],"domain_scores_gemma":[0.9983303,0.00025696802,0.00084507384,0.000106983454,0.00017268777,0.00028797673],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006506907,0.00043840238,0.0022097533,0.00025355126,0.000046316603,0.000027141794,0.00018195884,0.00003589265,0.000015779371],"category_scores_gemma":[0.000058073667,0.00025872432,0.00021714589,0.00030954953,0.00015550663,0.00007518475,0.00013964444,0.0008951597,0.0000015439276],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006379787,0.0003539124,0.0069717024,0.008512548,0.0015660431,0.0005497035,0.0018695953,0.000003103794,0.000044601107,0.000005010503,0.0010918042,0.978394],"study_design_scores_gemma":[0.008816056,0.0005417494,0.053452127,0.008165905,0.008376083,0.0001044405,0.00015914865,0.000008873349,0.0002181799,0.000007875971,0.9197281,0.00042145615],"about_ca_topic_score_codex":0.0000023998678,"about_ca_topic_score_gemma":6.161383e-8,"teacher_disagreement_score":0.97797257,"about_ca_system_score_codex":0.000015193205,"about_ca_system_score_gemma":0.00005806787,"threshold_uncertainty_score":0.99998647},"labels":[],"label_agreement":null},{"id":"W3010713619","doi":"10.1007/s13318-020-00613-9","title":"An Open-Label, Randomized, Single-Dose, Crossover, Comparative Pharmacokinetics Study of YLB113 and the Etanercept Reference Product in Healthy Adult Male Subjects","year":2020,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"Mylan","keywords":"Etanercept; Bioequivalence; Pharmacokinetics; Medicine; Crossover study; Rheumatoid arthritis; Cmax; Adverse effect; Pharmacology; Bioavailability; Area under the curve; Internal medicine; Placebo; Pathology","score_opus":0.05813416649355184,"score_gpt":0.3227903275896076,"score_spread":0.2646561610960557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010713619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799066,0.015001771,0.000052650706,0.00092461304,0.0015722241,0.0009645463,0.000011464543,0.000010146667,0.0015559876],"genre_scores_gemma":[0.9922076,0.0058962842,0.00012443191,0.001231385,0.0001689778,0.0000048315032,0.000011622261,0.00002599728,0.00032889977],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9928578,0.0052776444,0.0011975109,0.00030775,0.00011890691,0.00024040326],"domain_scores_gemma":[0.99799454,0.00033648638,0.0009558328,0.0001868728,0.00043391867,0.0000923677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019302816,0.0002799488,0.0010390007,0.00013046684,0.00015588387,0.0000992287,0.0005223086,0.00002950587,0.00020159708],"category_scores_gemma":[0.00018556295,0.00018589974,0.00004998715,0.0002463036,0.00048711887,0.00034013315,0.00020265141,0.00087884563,0.000012765463],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41896412,0.0035356972,0.0004536836,0.00011024075,0.0008204286,0.000069625305,0.059271812,0.0003189279,0.49863672,0.00027769522,0.0085171675,0.009023897],"study_design_scores_gemma":[0.8550911,0.0043765972,0.004500795,0.00012140551,0.0012488278,0.0005978411,0.010478077,0.00072651985,0.061098658,0.000022916134,0.06114494,0.0005923391],"about_ca_topic_score_codex":0.000050980554,"about_ca_topic_score_gemma":0.0000057798784,"teacher_disagreement_score":0.43753806,"about_ca_system_score_codex":0.000008970984,"about_ca_system_score_gemma":0.000040368304,"threshold_uncertainty_score":0.75807714},"labels":[],"label_agreement":null},{"id":"W3103380217","doi":"10.1007/s13318-020-00657-x","title":"Clinical Pharmacokinetics and Pharmacodynamics of Anti-Tubercular Drugs in Pregnancy","year":2020,"lang":"en","type":"review","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Alberta Hospital","funders":"","keywords":"Medicine; Pharmacokinetics; Observational study; Pregnancy; Intensive care medicine; Drug; MEDLINE; Population; Pharmacology; Drugs in pregnancy; Tuberculosis; Internal medicine; Fetus; Pathology","score_opus":0.05753270301240759,"score_gpt":0.4023705688796793,"score_spread":0.3448378658672717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3103380217","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011747506,0.9853949,0.000035801117,0.00064060395,0.000829766,0.0007450138,0.00012044748,0.000015046207,0.00047093967],"genre_scores_gemma":[0.006917454,0.98982614,0.0011803313,0.0004213821,0.0014213334,0.0000034743425,0.000031639986,0.00015686458,0.000041403244],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98989624,0.0043722535,0.0039285696,0.0005921322,0.00061003474,0.0006008013],"domain_scores_gemma":[0.9953888,0.0010168946,0.0018280892,0.00032330834,0.00034314115,0.0010997682],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0040039723,0.0007288705,0.0051282262,0.0007162542,0.000045253808,0.000033017368,0.0005377862,0.00015776907,0.00006035107],"category_scores_gemma":[0.0007926455,0.0005540627,0.0009081453,0.00063620723,0.0005042194,0.00012880011,0.0004300628,0.0029023208,0.000010935187],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018475452,0.00033750274,0.0007154964,0.011761928,0.0012513424,0.0016581264,0.00032966505,0.000018668097,0.00009916101,0.000027049564,0.0019712036,0.9816451],"study_design_scores_gemma":[0.005831496,0.00027256412,0.0013074344,0.009236619,0.0067366506,0.0009711813,0.000038976614,0.0007772139,0.00003376603,0.0000121817375,0.9743631,0.00041885022],"about_ca_topic_score_codex":0.0000038449725,"about_ca_topic_score_gemma":1.8746954e-7,"teacher_disagreement_score":0.98122627,"about_ca_system_score_codex":0.00002914726,"about_ca_system_score_gemma":0.00033746127,"threshold_uncertainty_score":0.99969107},"labels":[],"label_agreement":null},{"id":"W3114373673","doi":"10.1007/s13318-020-00666-w","title":"Parameterization of Microsomal and Cytosolic Scaling Factors: Methodological and Biological Considerations for Scalar Derivation and Validation","year":2020,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; Genentech","keywords":"Microsome; Cytosol; Biochemistry; Biology; Enzyme kinetics; Enzyme; Computational biology","score_opus":0.3040208151044591,"score_gpt":0.41808110510860486,"score_spread":0.11406029000414575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3114373673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793999,0.009730767,0.008665515,0.0013201495,0.00035749763,0.00034334988,0.0001257499,0.000015976482,0.00004108642],"genre_scores_gemma":[0.9690972,0.013247976,0.01578149,0.001340595,0.00048495826,0.0000028611928,0.000016099964,0.000025112739,0.0000036889157],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968155,0.0016858005,0.00084329845,0.0002910977,0.0001338975,0.00023039462],"domain_scores_gemma":[0.9974435,0.0012366914,0.00058427855,0.000059753103,0.00026219632,0.00041359026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018196219,0.00026184446,0.00058129866,0.00012414384,0.00021410116,0.000069562964,0.00010302044,0.00009286359,0.000039896477],"category_scores_gemma":[0.0007520175,0.00021223626,0.000077712204,0.00012651544,0.0003850215,0.00016910775,0.00013227014,0.00039711915,3.3844194e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055639807,0.00009476542,0.006195276,0.0001439336,0.00022070463,0.000013379717,0.0044896794,0.00029197938,0.95484334,0.00092296564,0.00022537317,0.03200223],"study_design_scores_gemma":[0.013474746,0.00051722996,0.08456462,0.000051890926,0.0020503358,0.00026381353,0.00077129144,0.010248414,0.84318334,0.0026369025,0.041551426,0.0006859871],"about_ca_topic_score_codex":0.0000010919683,"about_ca_topic_score_gemma":6.8595575e-8,"teacher_disagreement_score":0.11165997,"about_ca_system_score_codex":0.0000033268434,"about_ca_system_score_gemma":0.000026453687,"threshold_uncertainty_score":0.86547434},"labels":[],"label_agreement":null},{"id":"W3129001574","doi":"10.1007/s13318-020-00661-1","title":"Feasibility of Using Oral Fluid for Therapeutic Drug Monitoring of Antiepileptic Drugs","year":2021,"lang":"en","type":"review","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Lacosamide; Lamotrigine; Therapeutic drug monitoring; Oxcarbazepine; Levetiracetam; Carbamazepine; Topiramate; Primidone; Valproic Acid; Epilepsy; Phenytoin; Intensive care medicine; Pharmacology; Drug; Psychiatry","score_opus":0.13362715905784622,"score_gpt":0.42060617591100713,"score_spread":0.2869790168531609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129001574","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.039430466,0.9586755,0.00012894593,0.000034039535,0.0007426095,0.00075321447,0.00012493142,0.0000056262684,0.00010464887],"genre_scores_gemma":[0.036016297,0.9574569,0.005384643,0.00001341996,0.00088751107,0.0000023216373,0.00001892671,0.00009761442,0.00012240883],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99562895,0.0013622275,0.0017442029,0.0002952033,0.00061502965,0.0003544069],"domain_scores_gemma":[0.99670255,0.00037682266,0.0013540755,0.00036246446,0.0008321671,0.00037194384],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024512622,0.0004428852,0.0029569482,0.00035866187,0.00006134953,0.000029556679,0.0002854824,0.000046900906,0.0000349024],"category_scores_gemma":[0.0001250016,0.00031283224,0.0010628169,0.00035521886,0.0001862229,0.00008520476,0.00012301748,0.0005838553,0.000001010629],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037392997,0.00077640166,0.0020021677,0.025459113,0.0028179067,0.00026552845,0.00081187347,0.000009010529,0.0010507135,0.000026442958,0.00035690464,0.96605],"study_design_scores_gemma":[0.013119151,0.00064311095,0.0022100229,0.033880625,0.03707148,0.00082649256,0.0006080774,0.00008058153,0.00588045,0.000041922238,0.904912,0.0007261153],"about_ca_topic_score_codex":0.0000036038746,"about_ca_topic_score_gemma":4.888283e-8,"teacher_disagreement_score":0.96532387,"about_ca_system_score_codex":0.000046272402,"about_ca_system_score_gemma":0.0004845977,"threshold_uncertainty_score":0.99993235},"labels":[],"label_agreement":null},{"id":"W3168209064","doi":"10.1007/s13318-021-00691-3","title":"Comparison of Various Approaches to Translate Non-Linear Pharmacokinetics of Monoclonal Antibodies from Cynomolgus Monkey to Human","year":2021,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada","funders":"","keywords":"Pharmacokinetics; Monoclonal antibody; Allometry; Linear model; Pharmacology; Computational biology; Biology; Mathematics; Antibody; Statistics; Immunology","score_opus":0.1120842642260087,"score_gpt":0.372265443825211,"score_spread":0.2601811795992023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168209064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98180276,0.011354684,0.0014536754,0.0021670386,0.00040846822,0.0002764798,0.0002718738,0.000009301311,0.0022557217],"genre_scores_gemma":[0.9718545,0.0022096871,0.023966014,0.00040691026,0.0009370909,0.0000011897679,0.00003859153,0.000063676394,0.0005223251],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964014,0.00045983098,0.0015115307,0.0003515812,0.0008733169,0.00040233627],"domain_scores_gemma":[0.99770725,0.00016736666,0.00047484608,0.000277028,0.00063630234,0.00073721405],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007956062,0.00036566405,0.0013148553,0.0003484534,0.00009527701,0.00003045279,0.0003938881,0.00004079699,0.00019217537],"category_scores_gemma":[0.00006390894,0.00030511065,0.0003223664,0.00045803745,0.00019019165,0.00007827266,0.00024813044,0.0006390218,0.000012285147],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002368176,0.0013803841,0.019895025,0.0005422446,0.0013075353,0.00090193213,0.011738022,0.0033976827,0.9131771,0.00011947663,0.0047814534,0.040390998],"study_design_scores_gemma":[0.0053393636,0.00073590584,0.116361365,0.00042910787,0.0014826425,0.00020043198,0.00058097765,0.0018999381,0.8003492,0.000093645256,0.07209269,0.00043478393],"about_ca_topic_score_codex":0.000052724998,"about_ca_topic_score_gemma":0.0000033935582,"teacher_disagreement_score":0.11282792,"about_ca_system_score_codex":0.000010521161,"about_ca_system_score_gemma":0.00011893294,"threshold_uncertainty_score":0.9999401},"labels":[],"label_agreement":null},{"id":"W3182651484","doi":"10.1007/s13318-021-00699-9","title":"Novel Synthetic Analogues of 19(S/R)-Hydroxyeicosatetraenoic Acid Exhibit Noncompetitive Inhibitory Effect on the Activity of Cytochrome P450 1A1 and 1B1","year":2021,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Eicosanoids and Hypertension Pharmacology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Hydroxyeicosatetraenoic acid; Inhibitory postsynaptic potential; Cytochrome P450; Chemistry; Stereochemistry; Clinical chemistry; Pharmacology; Biochemistry; Arachidonic acid; Biology; Endocrinology; Enzyme","score_opus":0.012567622099569133,"score_gpt":0.24786859632867014,"score_spread":0.235300974229101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182651484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869892,0.011246056,0.00021252988,0.00041315626,0.00027403948,0.0001244287,0.000091177026,0.0000030678023,0.0006463386],"genre_scores_gemma":[0.9938731,0.004806727,0.0002655325,0.00054640893,0.00040984844,0.0000011332895,0.000007612545,0.000032802443,0.00005682001],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977862,0.0010239134,0.00048915984,0.00026217007,0.00023943235,0.00019912957],"domain_scores_gemma":[0.99861676,0.00019966488,0.00049925694,0.00021818183,0.00029354414,0.00017258147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001125222,0.0002453651,0.0005210744,0.000104632614,0.000082122526,0.000019054783,0.0002137748,0.000047310117,0.00003554262],"category_scores_gemma":[0.00018396098,0.00016908589,0.00017758683,0.00013427302,0.00035971683,0.000011327073,0.0002041427,0.00034242767,0.0000011615147],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035741343,0.00022680186,0.00012681815,0.00008433583,0.00025691377,0.000075338045,0.00019937594,0.000043358283,0.9941518,0.00007878227,0.00069207203,0.0037070008],"study_design_scores_gemma":[0.0024016544,0.0006392014,0.013749071,0.00008620966,0.00040473248,0.00034106543,0.00007437977,0.000041563668,0.97055,0.00001347753,0.0115322685,0.00016637107],"about_ca_topic_score_codex":0.0000022157467,"about_ca_topic_score_gemma":0.0000010695339,"teacher_disagreement_score":0.023601785,"about_ca_system_score_codex":0.0000043462082,"about_ca_system_score_gemma":0.000076905344,"threshold_uncertainty_score":0.68951225},"labels":[],"label_agreement":null},{"id":"W3209630012","doi":"10.1007/s13318-021-00723-y","title":"Effects of Cytochrome P450 3A4 Induction and Inhibition on the Pharmacokinetics of BI 425809, a Novel Glycine Transporter 1 Inhibitor","year":2021,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Amino Acid Enzymes and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"Boehringer Ingelheim","keywords":"Pharmacology; Pharmacokinetics; Cmax; CYP3A4; Itraconazole; Rifampicin; Oral administration; Chemistry; Cytochrome P450; Medicine; Internal medicine; Metabolism; Biochemistry; Antibiotics","score_opus":0.00952196338194641,"score_gpt":0.23058577654593843,"score_spread":0.221063813163992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209630012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825926,0.014807949,0.0012091609,0.0004000597,0.000553384,0.00016522185,0.00005478516,0.0000033775073,0.00021347734],"genre_scores_gemma":[0.98350173,0.013844626,0.0008111355,0.00046925535,0.0011954423,0.0000015406563,0.000016405329,0.000040976676,0.00011889083],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982826,0.00033518093,0.0006706001,0.00023104611,0.00029133767,0.00018920552],"domain_scores_gemma":[0.998735,0.00005650296,0.000534869,0.00017977181,0.0003488906,0.00014495646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006201869,0.00024557873,0.00040119095,0.00010593073,0.000055942495,0.000019179528,0.0001356562,0.000048838952,0.000018979763],"category_scores_gemma":[0.000078779616,0.00017854068,0.00015230151,0.00018458618,0.0001999726,0.000016991738,0.00008480569,0.00028887545,5.6476284e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026818854,0.00022444798,0.000037194037,0.00016498804,0.00016838532,0.000038779235,0.00045110166,0.00006242572,0.99089515,0.0001459243,0.0011229807,0.0064204107],"study_design_scores_gemma":[0.003830684,0.00022723636,0.018561922,0.00012446864,0.00052974833,0.00012784886,0.00011032628,0.000020141899,0.92681086,0.000016895916,0.04947177,0.00016807206],"about_ca_topic_score_codex":0.0000013630003,"about_ca_topic_score_gemma":3.188032e-7,"teacher_disagreement_score":0.06408429,"about_ca_system_score_codex":0.0000029520156,"about_ca_system_score_gemma":0.000047885947,"threshold_uncertainty_score":0.72806776},"labels":[],"label_agreement":null},{"id":"W4249973290","doi":"10.1007/bf03190048","title":"Preface","year":2000,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Human physiology; Medicine; Internal medicine","score_opus":0.014373154903693562,"score_gpt":0.25782973589456565,"score_spread":0.24345658099087208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249973290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9380415,0.015686475,0.000058570753,0.00033278245,0.00055079034,0.000090307134,0.00004267873,0.000041431806,0.045155454],"genre_scores_gemma":[0.9855768,0.006515352,0.0025617005,0.0004660625,0.0015026606,2.3362155e-7,0.0000019669403,0.00012561014,0.0032496315],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972709,0.0010560924,0.0007229846,0.00017527743,0.00045838504,0.00031640747],"domain_scores_gemma":[0.9987854,0.00005711343,0.00036891145,0.00019198401,0.00018901132,0.0004076194],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0018622415,0.00025005732,0.00036336054,0.00017204636,0.00009429126,0.00009801851,0.00044144804,0.000012428161,0.0021686296],"category_scores_gemma":[0.00003778597,0.0002033501,0.00013477677,0.00027235787,0.00013270217,0.00030523163,0.000055429762,0.00047391752,0.0010296883],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010584026,0.00045651718,0.0005987824,0.00006386954,0.00047189253,0.0011694122,0.006829855,0.0024802068,0.11205036,0.00026249778,0.1854371,0.6891211],"study_design_scores_gemma":[0.0032500888,0.000047750862,0.020124124,0.00003572452,0.0003975091,0.00049556047,0.000062166386,0.00013358478,0.009777644,0.00006658476,0.9653602,0.0002490487],"about_ca_topic_score_codex":0.00000119816,"about_ca_topic_score_gemma":1.2125618e-7,"teacher_disagreement_score":0.77992314,"about_ca_system_score_codex":0.000007964924,"about_ca_system_score_gemma":0.000023687247,"threshold_uncertainty_score":0.9997481},"labels":[],"label_agreement":null},{"id":"W4283646822","doi":"10.1007/s13318-022-00779-4","title":"Drug Dosing in Critically Ill Adult Patients with Augmented Renal Clearance","year":2022,"lang":"en","type":"review","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Dosing; Medicine; Intensive care medicine; MEDLINE; Meropenem; Therapeutic drug monitoring; Internal medicine; Drug; Pharmacology; Antibiotics","score_opus":0.020594148163452907,"score_gpt":0.2995362152240217,"score_spread":0.2789420670605688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283646822","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00963424,0.9868306,0.000075728356,0.00030888352,0.00085903023,0.0006497568,0.00009741315,0.000020020674,0.0015243476],"genre_scores_gemma":[0.004135566,0.99147534,0.0018615056,0.0012027703,0.00082052033,0.0000016098775,0.00006386329,0.00020008557,0.0002387113],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953227,0.0011097421,0.0017130238,0.00044064075,0.0008996641,0.00051425386],"domain_scores_gemma":[0.9971382,0.00019959052,0.0009931861,0.0002872745,0.0008594938,0.0005222545],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011652793,0.00064081175,0.0020322439,0.00060443947,0.000120578334,0.00008291831,0.00043715723,0.000043629632,0.00027017872],"category_scores_gemma":[0.00024237004,0.00046761867,0.00039546605,0.00059839414,0.00018815394,0.00011488085,0.00022944149,0.0020389494,0.000011378374],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083505095,0.00096082326,0.00019149964,0.005414865,0.00060304534,0.0018252038,0.0005187948,0.000036670328,0.000016902257,0.000053191954,0.0041744695,0.9853695],"study_design_scores_gemma":[0.0077819913,0.00021356395,0.0018988805,0.0069083213,0.004333331,0.00031294665,0.00005082869,0.000046936697,0.00001623959,0.0000026660052,0.9779566,0.00047770236],"about_ca_topic_score_codex":0.000002409098,"about_ca_topic_score_gemma":3.054257e-7,"teacher_disagreement_score":0.9848918,"about_ca_system_score_codex":0.000057350175,"about_ca_system_score_gemma":0.00019533369,"threshold_uncertainty_score":0.99977756},"labels":[],"label_agreement":null},{"id":"W4380785854","doi":"10.1007/s13318-023-00835-7","title":"Early At-Home Measurement of Adalimumab Concentrations to Guide Anti-TNF Precision Dosing: A Pilot Study","year":2023,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Adalimumab; Medicine; Internal medicine; Pharmacokinetics; Population; Dosing; Gastroenterology; Rheumatoid arthritis","score_opus":0.05780076161012206,"score_gpt":0.3190729579071068,"score_spread":0.2612721962969848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380785854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991397,0.0051142997,0.0004757823,0.00068388385,0.0013506119,0.00029318462,0.000048611364,0.00002057853,0.00061604404],"genre_scores_gemma":[0.99701387,0.0010561079,0.0008884943,0.00019422585,0.00015157295,9.5129167e-7,0.0000020631796,0.000024223375,0.00066850777],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9968913,0.0014783712,0.00091770286,0.00021003501,0.00022313962,0.00027944506],"domain_scores_gemma":[0.99873435,0.00014562052,0.00035976843,0.00018732005,0.00044894882,0.00012396937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034982415,0.00019281848,0.00048397764,0.00022835917,0.00013576246,0.000028530878,0.00032132337,0.000021788801,0.000137138],"category_scores_gemma":[0.00018921318,0.00014262472,0.0000981889,0.00040346722,0.000119583485,0.00006417771,0.00021323255,0.00027494098,0.000041986856],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073594763,0.00064138515,0.002441219,0.000021800832,0.0004985014,0.000062122446,0.0019700285,0.00006226772,0.95167285,0.00004737691,0.022707948,0.019138534],"study_design_scores_gemma":[0.0093067605,0.0031201807,0.43396124,0.00015345306,0.0013096002,0.00008536225,0.0006334089,0.000020329764,0.2349302,0.000046021934,0.3160324,0.0004010187],"about_ca_topic_score_codex":0.0000064214264,"about_ca_topic_score_gemma":0.0000014691765,"teacher_disagreement_score":0.71674263,"about_ca_system_score_codex":0.000018012663,"about_ca_system_score_gemma":0.00004149355,"threshold_uncertainty_score":0.5816067},"labels":[],"label_agreement":null},{"id":"W4387472477","doi":"10.1007/s13318-023-00857-1","title":"The Effects of 16-HETE Enantiomers on Hypertrophic Markers in Human Fetal Ventricular Cardiomyocytes, RL-14 Cells","year":2023,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Eicosanoids and Hypertension Pharmacology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Biology; CYP1B1; Gene expression; Cytochrome P450; Endocrinology; Biochemistry; Gene; Enzyme","score_opus":0.006939423227047406,"score_gpt":0.2388003516835937,"score_spread":0.2318609284565463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387472477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851067,0.012767196,0.000018047165,0.00020645514,0.0013319593,0.00014915438,0.000012311837,0.000005328295,0.00040281372],"genre_scores_gemma":[0.9783246,0.020519529,0.0000424432,0.0003069124,0.0004783471,0.0000016309465,0.000010177915,0.00003778341,0.00027860416],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99792904,0.00081375317,0.00050987926,0.00020064086,0.0002495244,0.00029718736],"domain_scores_gemma":[0.9991342,0.00010631144,0.00030254782,0.00018290193,0.0001312982,0.0001427414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011807809,0.00019849843,0.00033786005,0.00020222606,0.0001188459,0.000023849432,0.0003049027,0.00003658781,0.0000075768435],"category_scores_gemma":[0.00008093837,0.00013710248,0.00019765389,0.0002625527,0.00015560491,0.000006368837,0.00013880574,0.00028499577,0.0000042106753],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025641016,0.00006963394,0.00020087913,0.00006184374,0.00021469036,0.0005668354,0.00006930301,0.00028638265,0.9704867,0.000021096219,0.018424535,0.009341669],"study_design_scores_gemma":[0.0047771414,0.00048898754,0.010440217,0.00006444057,0.00032603412,0.00010965449,0.000069539354,0.00006330028,0.68345493,0.000029163468,0.29994255,0.00023400398],"about_ca_topic_score_codex":0.0000027834965,"about_ca_topic_score_gemma":5.73415e-7,"teacher_disagreement_score":0.28703177,"about_ca_system_score_codex":0.0000061943883,"about_ca_system_score_gemma":0.000029047029,"threshold_uncertainty_score":0.5590877},"labels":[],"label_agreement":null},{"id":"W4390048756","doi":"10.1007/s13318-023-00873-1","title":"Pharmacokinetics of Long-Acting Methylphenidate: Formulation Differences, Bioequivalence, Interchangeability","year":2023,"lang":"en","type":"review","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Bioequivalence; Interchangeability; Pharmacokinetics; Medicine; Pharmacology; Methylphenidate; Computer science; Clinical psychology","score_opus":0.15939712643748805,"score_gpt":0.40506528951163384,"score_spread":0.2456681630741458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390048756","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025752159,0.9704976,0.0010994686,0.0000875853,0.0013309536,0.0006833421,0.0001337176,0.000043081243,0.00037207032],"genre_scores_gemma":[0.036021695,0.96143925,0.00094870676,0.00004164643,0.0009564207,0.000002941168,0.00004848186,0.00016146574,0.00037939922],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946229,0.0015147101,0.0023311889,0.00040023273,0.00075819995,0.00037278194],"domain_scores_gemma":[0.9953464,0.000560783,0.002763866,0.00036133244,0.00062681135,0.00034076505],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025769463,0.0006117664,0.0027177823,0.0007921569,0.00007433755,0.00005551607,0.0004191997,0.00009513575,0.00018505329],"category_scores_gemma":[0.00037534948,0.00046683173,0.00082610385,0.00079338165,0.00018182989,0.00022965916,0.00030555684,0.0013026522,0.00002699139],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011019125,0.00027178947,0.00027042898,0.019056037,0.0010300594,0.00021095593,0.00056937226,0.000006122794,0.00023151866,0.00001563856,0.00029732074,0.97793055],"study_design_scores_gemma":[0.0044100825,0.00030608627,0.003868385,0.0154674845,0.024654754,0.00095720147,0.00050543196,0.00021270059,0.00020731946,0.000025922,0.9484976,0.00088701304],"about_ca_topic_score_codex":0.0000035237813,"about_ca_topic_score_gemma":5.968022e-7,"teacher_disagreement_score":0.97704357,"about_ca_system_score_codex":0.000038055958,"about_ca_system_score_gemma":0.00020514902,"threshold_uncertainty_score":0.99977833},"labels":[],"label_agreement":null},{"id":"W4396653776","doi":"10.1007/s13318-024-00897-1","title":"Does Sample Size, Sampling Strategy, or Handling of Concentrations Below the Lower Limit of Quantification Matter When Externally Evaluating Population Pharmacokinetic Models?","year":2024,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Polytechnique Montréal","funders":"Fonds de Recherche du Québec - Santé; Canada Foundation for Innovation; Réseau Québécois de Recherche sur les Médicaments","keywords":"Sample size determination; NONMEM; Sampling (signal processing); Statistics; Population; Sample (material); Dosing; Pharmacokinetics; Medicine; Computer science; Econometrics; Mathematics; Pharmacology; Chromatography; Environmental health","score_opus":0.06829661251966955,"score_gpt":0.35187229925380314,"score_spread":0.2835756867341336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396653776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96400845,0.0069950917,0.02526423,0.0014178045,0.0014425876,0.00043063483,0.00010314171,0.00002068633,0.0003173934],"genre_scores_gemma":[0.97947454,0.004882094,0.014183994,0.00023313065,0.0008799188,9.1666936e-7,0.00001318213,0.00006634581,0.0002658701],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9970472,0.00040771803,0.0014221219,0.00025769215,0.0006110755,0.00025422283],"domain_scores_gemma":[0.99730575,0.0009812289,0.0007264415,0.00022667141,0.00058433926,0.00017558459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018271648,0.00026826144,0.0005092265,0.00018742967,0.000113516224,0.00012425508,0.0002640382,0.00003113587,0.00043282716],"category_scores_gemma":[0.00024759158,0.00014589545,0.00021246227,0.00027828242,0.00016123877,0.00023688453,0.00007451767,0.0004756947,0.0000037011112],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023631577,0.0008578065,0.0047953287,0.0019749638,0.0014035087,0.00012184965,0.006546621,0.079326354,0.75172055,0.00088578096,0.0022183298,0.14778572],"study_design_scores_gemma":[0.014269984,0.0014213306,0.18346979,0.005022853,0.0144664245,0.000556672,0.0013030198,0.6159612,0.14027618,0.0045965766,0.017392678,0.0012633215],"about_ca_topic_score_codex":0.00002205057,"about_ca_topic_score_gemma":0.0000010811182,"teacher_disagreement_score":0.6114444,"about_ca_system_score_codex":0.000014236904,"about_ca_system_score_gemma":0.00011120885,"threshold_uncertainty_score":0.5949444},"labels":[],"label_agreement":null},{"id":"W4402580814","doi":"10.1007/s13318-024-00913-4","title":"Vancomycin in Pediatric Patients with Cystic Fibrosis: Dose Optimization Using Population Pharmacokinetic Approach","year":2024,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"Faculté de pharmacie, Université de Montréal; Fonds de Recherche du Québec - Santé","keywords":"Cystic fibrosis; Medicine; Vancomycin; Therapeutic drug monitoring; Pharmacokinetics; Antibiotics; Intensive care medicine; Population; Staphylococcus aureus; Drug; Population pharmacokinetics; Internal medicine; Pharmacology; Microbiology","score_opus":0.011781385841971428,"score_gpt":0.26011200746278657,"score_spread":0.24833062162081515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402580814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97101843,0.010666886,0.016827885,0.00005856247,0.00059461046,0.0003581213,0.00002054292,0.000027444166,0.0004275317],"genre_scores_gemma":[0.95341206,0.0016023285,0.043980557,0.00009468483,0.00076921796,8.6728454e-7,0.000023479915,0.00007650043,0.000040318235],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99803174,0.0003418849,0.0007191779,0.00024822663,0.00040872846,0.00025024056],"domain_scores_gemma":[0.9991168,0.000066051056,0.00029067753,0.00011482243,0.00021775303,0.00019389407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062222173,0.0002515351,0.0004058212,0.00056509103,0.00004993053,0.00008579225,0.00011676422,0.000024763911,0.000026969035],"category_scores_gemma":[0.00004583325,0.0001930827,0.000084454594,0.00071967527,0.000049865288,0.00027174852,0.000042157928,0.00044985564,0.0000021921662],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062240325,0.0017711818,0.26685768,0.004596612,0.00055157335,0.001639202,0.0037899327,0.6385456,0.011853601,0.00006676753,0.003067679,0.061036184],"study_design_scores_gemma":[0.01496547,0.00030047135,0.8544625,0.0011131113,0.003957746,0.00022271794,0.000101676975,0.119079575,0.00054861046,0.000016945189,0.0045619737,0.0006692059],"about_ca_topic_score_codex":0.0000030931258,"about_ca_topic_score_gemma":1.9064365e-7,"teacher_disagreement_score":0.5876048,"about_ca_system_score_codex":0.000044196237,"about_ca_system_score_gemma":0.00006497339,"threshold_uncertainty_score":0.78736836},"labels":[],"label_agreement":null},{"id":"W4412711389","doi":"10.1007/s13318-025-00960-5","title":"Population Pharmacokinetic Model Evaluation with a Small Real-World Dataset Versus a Large Virtual Dataset: Does Sample Size Affect Decision-Making?","year":2025,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Polytechnique Montréal; McGill University Health Centre; Université de Montréal","funders":"Fonds de Recherche du Québec - Santé","keywords":"Affect (linguistics); Sample size determination; Sample (material); Pharmacokinetics; Population; Statistics; Medicine; Computer science; Psychology; Internal medicine; Mathematics; Chemistry; Chromatography; Environmental health","score_opus":0.0685641862903685,"score_gpt":0.42004607954738077,"score_spread":0.3514818932570123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412711389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9487423,0.007732293,0.012891417,0.00074380933,0.0073847063,0.0013996542,0.01865626,0.000084244435,0.0023653281],"genre_scores_gemma":[0.97678417,0.0075354786,0.0100948075,0.0030246286,0.001198613,0.000021428892,0.0010761045,0.00011291489,0.00015186501],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927539,0.003188374,0.0015548775,0.000743179,0.00089633773,0.00086332264],"domain_scores_gemma":[0.99380916,0.0033656363,0.0010867051,0.00055389485,0.0005769939,0.0006076041],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0066897767,0.00076279714,0.0009832998,0.00077633746,0.0005168012,0.00017736129,0.00102768,0.000107020234,0.0008560771],"category_scores_gemma":[0.00085852767,0.00057801465,0.00020407357,0.00091050065,0.00023950258,0.00040618074,0.00048610335,0.0014721393,0.000018917077],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0300217,0.0025522197,0.005782965,0.00040724358,0.0039642234,0.0005821407,0.0023295523,0.16822758,0.02854597,0.0023190468,0.13820197,0.61706537],"study_design_scores_gemma":[0.045430355,0.000304989,0.018569188,0.00030961103,0.011928317,0.000056778546,0.00021208126,0.17221561,0.007267186,0.0016940329,0.7406403,0.0013715471],"about_ca_topic_score_codex":0.000028604649,"about_ca_topic_score_gemma":0.00008613047,"teacher_disagreement_score":0.61569387,"about_ca_system_score_codex":0.00008181215,"about_ca_system_score_gemma":0.00028728868,"threshold_uncertainty_score":0.9996671},"labels":[],"label_agreement":null}]}